These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7538709)

  • 1. [Status of phytotherapeutic drugs in treatment of benign prostatic hyperplasia].
    Dreikorn K; Schönhöfer PS
    Urologe A; 1995 Mar; 34(2):119-29. PubMed ID: 7538709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [With alpha blockers, finasteride and nettle root against benign prostatic hyperplasia. Which patients are helped by conservative therapy?].
    Vahlensieck W
    MMW Fortschr Med; 2002 Apr; 144(16):33-6. PubMed ID: 12043098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current drug therapy of benign prostatic hyperplasia].
    Schmidbauer CP; Madersbacher S
    Wien Med Wochenschr; 1996; 146(8):161-4. PubMed ID: 8767400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy for benign prostatic syndrome (BPS)].
    Berges R
    Aktuelle Urol; 2006 Sep; 37(5):351-62. PubMed ID: 17004180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of D-004, a lipid extract from Cuban royal palm fruit, on histological changes of prostate hyperplasia induced with testosterone in rats.
    Noa M; Arruzazabala ML; Carbajal D; Más R; Molina V
    Int J Tissue React; 2005; 27(4):203-11. PubMed ID: 16440586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plant extracts: sense or nonsense?
    Madersbacher S; Berger I; Ponholzer A; Marszalek M
    Curr Opin Urol; 2008 Jan; 18(1):16-20. PubMed ID: 18090484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saw palmetto extracts for benign prostatic hyperplasia.
    Segars LW
    J Fam Pract; 1999 Feb; 48(2):88-9. PubMed ID: 10037530
    [No Abstract]   [Full Text] [Related]  

  • 8. Future aspects of plant derived bioactive metabolites as therapeutics to combat benign prostatic hyperplasia.
    Krishnamoorthi R; Ganapathy A A; Hari Priya VM; Kumaran A
    J Ethnopharmacol; 2024 Aug; 330():118207. PubMed ID: 38636573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Benign prostatic hyperplasia: medical therapy].
    Schlenker B; Gratzke C; Weidlich P; Seitz M; Reich O; Stief CG
    MMW Fortschr Med; 2007 Aug; 149(33-34):29-31; quiz 32. PubMed ID: 17912863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Benign prostatic hyperplasia--treatment with sabal fruit extract. A treatment study of 1,334 patients].
    Vahlensieck W; Völp A; Lubos W; Kuntze M
    Fortschr Med; 1993 Jun; 111(18):323-6. PubMed ID: 7689525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Established and upcoming new options in medical therapy for benign prostatic hyperplasia].
    Schlenker B; Beer AM; Gratzke C; Tilki D; Seitz M; Stief CG; Reich O
    MMW Fortschr Med; 2009 Oct; 151(41):33-6. PubMed ID: 19891182
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis and management of benign prostatic hyperplasia.
    Edwards JL
    Am Fam Physician; 2008 May; 77(10):1403-10. PubMed ID: 18533373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibiting effects of Urtica dioica root extracts on experimentally induced prostatic hyperplasia in the mouse.
    Lichius JJ; Muth C
    Planta Med; 1997 Aug; 63(4):307-10. PubMed ID: 9270373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE.
    Roehrborn CG
    BJU Int; 2008 Mar; 101 Suppl 3():17-21. PubMed ID: 18307681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Novel therapeutics strategies in benign hypertrophy of prostate management].
    Roumeguère T
    Rev Med Brux; 2005 Sep; 26(4):S407-11. PubMed ID: 16240894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of 5-alpha-reductase inhibitors on benign prostatic hyperplasia].
    Djavan B; McConnell J
    Wien Med Wochenschr; 1996; 146(8):165-8. PubMed ID: 8767401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacotherapy in benign prostatic hyperplasia].
    Hauri D
    Ther Umsch; 1995 Jun; 52(6):378-82. PubMed ID: 7541566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term administration of finasteride (MK-906), an inhibitor of 5 alpha-reductase, in patients with benign prostatic hyperplasia.
    Yoshida O; Oishi K; Okada Y; Mizutani Y; Itokawa Y; Tomoyoshi T; Okada K; Komatz Y; Matsuda T; Takeuchi H
    Hinyokika Kiyo; 1996 Apr; 42(4):323-31. PubMed ID: 8693970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What do we know about phytotherapy of benign prostatic hyperplasia?
    Allkanjari O; Vitalone A
    Life Sci; 2015 Apr; 126():42-56. PubMed ID: 25703069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytotherapeutic agents in the treatment of benign prostatic hyperplasia.
    Dreikorn K
    Curr Urol Rep; 2000 Aug; 1(2):103-9. PubMed ID: 12084323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.